🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/06/1976 | 1,83 | 1,84 | 1,80 | 1,81 | -0,73% | 2,36% | 1.701.533 |
| 14/06/1976 | 1,84 | 1,85 | 1,83 | 1,83 | -0,54% | 1,44% | 1.607.213 |
| 11/06/1976 | 1,79 | 1,84 | 1,79 | 1,84 | +2,59% | 2,77% | 1.569.485 |
| 10/06/1976 | 1,78 | 1,79 | 1,77 | 1,79 | +0,37% | 1,30% | 1.120.522 |
| 09/06/1976 | 1,78 | 1,79 | 1,75 | 1,78 | +0,19% | 2,23% | 1.765.670 |
| 08/06/1976 | 1,78 | 1,80 | 1,78 | 1,78 | +0,37% | 1,31% | 2.127.859 |
| 07/06/1976 | 1,78 | 1,78 | 1,77 | 1,77 | -0,19% | 0,75% | 1.629.850 |
| 04/06/1976 | 1,80 | 1,80 | 1,76 | 1,78 | -1,47% | 2,03% | 1.890.173 |
| 03/06/1976 | 1,83 | 1,84 | 1,80 | 1,80 | -1,27% | 1,81% | 1.992.038 |
| 02/06/1976 | 1,83 | 1,84 | 1,82 | 1,83 | -0,18% | 1,45% | 1.154.477 |
| 01/06/1976 | 1,86 | 1,86 | 1,82 | 1,83 | -1,43% | 1,78% | 1.169.568 |
| 28/05/1976 | 1,86 | 1,87 | 1,84 | 1,86 | -0,18% | 1,60% | 1.539.302 |
| 27/05/1976 | 1,86 | 1,86 | 1,84 | 1,86 | +0,18% | 1,07% | 1.667.578 |
| 26/05/1976 | 1,88 | 1,88 | 1,86 | 1,86 | -1,06% | 1,41% | 1.135.613 |
| 25/05/1976 | 1,89 | 1,89 | 1,86 | 1,88 | -1,04% | 1,58% | 1.139.386 |
| 24/05/1976 | 1,90 | 1,91 | 1,89 | 1,90 | -0,18% | 1,05% | 1.014.883 |
| 21/05/1976 | 1,91 | 1,92 | 1,90 | 1,90 | -0,52% | 1,04% | 965.837 |
| 20/05/1976 | 1,92 | 1,92 | 1,90 | 1,91 | -0,52% | 1,21% | 1.441.210 |
| 19/05/1976 | 1,91 | 1,92 | 1,90 | 1,92 | +0,69% | 1,04% | 1.158.250 |
| 18/05/1976 | 1,93 | 1,95 | 1,89 | 1,91 | -1,54% | 3,09% | 1.365.754 |
| 17/05/1976 | 1,95 | 1,95 | 1,93 | 1,93 | -0,85% | 1,02% | 1.418.573 |
| 14/05/1976 | 1,97 | 1,97 | 1,95 | 1,95 | -1,17% | 1,34% | 1.214.842 |
| 13/05/1976 | 1,99 | 1,99 | 1,96 | 1,97 | -0,99% | 1,33% | 1.988.266 |
| 12/05/1976 | 1,98 | 1,99 | 1,97 | 1,99 | +0,67% | 1,00% | 1.203.523 |
| 11/05/1976 | 1,99 | 2,00 | 1,98 | 1,98 | -0,66% | 1,16% | 1.565.712 |
| 10/05/1976 | 1,97 | 1,99 | 1,97 | 1,99 | +1,35% | 1,00% | 2.191.997 |
| 07/05/1976 | 1,97 | 1,98 | 1,96 | 1,97 | +0,00% | 1,01% | 1.154.477 |
| 06/05/1976 | 1,95 | 1,97 | 1,94 | 1,97 | +0,68% | 1,36% | 1.837.354 |
| 05/05/1976 | 1,97 | 1,98 | 1,94 | 1,95 | -0,67% | 1,69% | 1.546.848 |
| 04/05/1976 | 1,92 | 1,97 | 1,92 | 1,97 | +2,59% | 2,76% | 1.558.166 |